Concepedia

Hien Zhao

HZ

18

Publications

1.5K

Citations

16

H-Index

2016

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Broad Institute

Harvard University

Prion Alliance

Biogen (United States)

Hien Zhao is an author at Ionis Pharmaceuticals (United States) specializing in medicine, neurology, and neuroprotection.

ORCID

Top concepts

Publications per year

2016–2025

18

Publications

18

LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model

Hien Zhao, Neena John, Vedad Delic et al. · Molecular Therapy — Nucleic Acids · 2017 · 207 citations · Full text

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice

Hayley S. McLoughlin, Lauren R. Moore, Ravi Chopra et al. · Annals of Neurology · 2018 · 154 citations · Full text

PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models

Hien Zhao, Sagar Damle, Karli Ikeda-Lee et al. · Journal of Clinical Investigation · 2017 · 151 citations · Full text

, , +16

Antisense oligonucleotides extend survival of prion-infected mice

Gregory J. Raymond, Hien Zhao, Brent Race et al. · JCI Insight · 2019 · 140 citations · Full text

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

Eric Vallabh Minikel, Hien Zhao, Jason Le et al. · Nucleic Acids Research · 2020 · 130 citations · Full text

, , +20

Rows per page

1–5 of 18